Essam Refai

835 citations
17 papers · 697 indexed · h-index 15
Topics
Pancreatic function and diabetes (7 papers)Neuroendocrine Tumor Research Advances (4 papers)Antimicrobial Peptides and Activities (4 papers)

In The Last Decade

Essam Refai

16 papers receiving 688 citations

Peers

Essam Refai
Comparison fields: 5 of 78
  • Molecular Biology 325
  • Surgery 200
  • Microbiology 172
  • Endocrinology, Diabetes and Metabolism 150
  • Immunology 93
Replace Rose E. Gaines Das with:
Rose E. Gaines Das United Kingdom
Zhaohui Chen China
Aaron C. Baldwin United States
Kerstin Lindgren Sweden
Annette Seibt Germany
Chris Ross United States
Ulla G. Knaus United States
Taila Mattern Germany
Yasushi Takamori Japan
Jeremy C. Parker United Kingdom
Essam Refai relative to Rose E. Gaines Das United Kingdom Rose E. Gaines Das's profile →
Citations per field
00.5×6.4×
Rose E. Gaines Das · 1×
Citations per year

Countries citing papers authored by Essam Refai

Since Specialization
Citations

This map shows the geographic impact of Essam Refai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Essam Refai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Essam Refai more than expected).

Fields of papers citing papers by Essam Refai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Essam Refai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Essam Refai. The network helps show where Essam Refai may publish in the future.

Co-authorship network of co-authors of Essam Refai

This figure shows the co-authorship network connecting the top 25 collaborators of Essam Refai. A scholar is included among the top collaborators of Essam Refai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Essam Refai. Essam Refai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 30
2 63
3 22
4 14
5 51
6 10
7 80
8 38
9 98
10 70
11 73
12 0
13 20
14 15
15 51
16 38
17 24

About Essam Refai

Essam Refai is a scholar working on Microbiology, Physiology and Neurology, having authored 17 papers that have together received 697 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (7 papers), Neuroendocrine Tumor Research Advances (4 papers) and Antimicrobial Peptides and Activities (4 papers). The work is most often cited by research in Microbiology (172 citations), Endocrinology, Diabetes and Metabolism (150 citations) and Molecular Biology (325 citations). Essam Refai has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Mats Andersson, Per‐Olof Berggren, Lisa Juntti‐Berggren, Jenny Karlsson, Katrin Pütsep, Mathias W. Hornef, Moustapha Hassan, Sven Hoffner, Gunilla Olivecrona and Cathrine Jonsson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Immunology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026